Ocrevus Ocrevus (ocrelizumab) is actually a monoclonal antibody that targets a specific type of white blood mobile—CD20 favourable B lymphocytes. Ocrevus is approved to take care of relapsing kinds of MS in Older people and likewise permitted to take care of Major progressive MS (PPMS) in Grownups.Together with its synthesis from indole-3-acetic